What does Navidea Biopharmaceuticals, Inc. do?

Jun 22 2025 06:06 PM IST
share
Share Via
Navidea Biopharmaceuticals, Inc. is a micro-cap biopharmaceutical company focused on developing precision immunodiagnostic agents and immunotherapeutics. As of September 2023, it reported a net profit loss of $2 million and has a market cap of $0.07 million.
Overview:
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -2 Million (Quarterly Results - Sep 2023)
Market-cap: USD 0.07 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: 0.80
Return on Equity: 294.84%
Price to Book: -0.02

Contact Details:
Address: 4995 Bradenton Ave Ste 240, DUBLIN OH: 43017-3552
Tel: ['1 614 7937500', '1 614 9737490']
Fax: 1 614 7937520
Website: https://www.navidea.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News